Protein study of brain tumor fluid
Part of Cancer clinical trials.
This study looks at proteins in the fluid around the brain and spine of people with glioblastoma to learn more about the tumor and find better ways to diagnose and treat it. You would give samples of fluid, blood, and tumor tissue, and have follow-up care at a specific hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of glioblastoma (a fast-growing brain tumor).
- You must be 18 years of age or older.
- You must be willing and able to receive follow-up care at the Regional Hospital 'Dr. Valentin Gomez Farias' ISSSTE.
- You must agree to provide samples of cerebrospinal fluid (fluid around the brain and spine), blood, and tumor tissue.
- You must be willing to voluntarily take part in this research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve understanding of glioblastoma (and gliosarcoma) by preserving live, usable brain-tissue samples during brain surgery. If you’re having repeat tumor surgery or your scans suggest these cancers, the study may ask to collect tissue for research.
This study is for adults with glioblastoma, a type of brain cancer. Researchers want to gather information about patients with this condition to better understand it and possibly improve future care. By joining, you help doctors learn more about glioblastoma.
This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.
This study tracks people with glioblastoma (a type of aggressive brain tumor) over time to understand what affects their health and quality of life. If you take part, you'll fill out online surveys to help researchers learn how to improve care.
This study looks at how male hormones (androgens) affect the immune cells around glioblastoma tumors. Researchers will analyze tumor tissue left over from surgery to learn more, which may help improve future treatments.
This study looks at tear fluid to find tiny particles released by glioblastoma tumors, which could offer a new way to monitor the disease. Participation involves a simple, non-invasive tear collection with a small paper strip.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.